473 related articles for article (PubMed ID: 26634783)
1. The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.
Sutti S; Bruzzì S; Albano E
Expert Rev Gastroenterol Hepatol; 2016; 10(2):243-53. PubMed ID: 26634783
[TBL] [Abstract][Full Text] [Related]
2. B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).
Bruzzì S; Sutti S; Giudici G; Burlone ME; Ramavath NN; Toscani A; Bozzola C; Schneider P; Morello E; Parola M; Pirisi M; Albano E
Free Radic Biol Med; 2018 Aug; 124():249-259. PubMed ID: 29920340
[TBL] [Abstract][Full Text] [Related]
3. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis.
Chackelevicius CM; Gambaro SE; Tiribelli C; Rosso N
World J Gastroenterol; 2016 Nov; 22(41):9096-9103. PubMed ID: 27895397
[TBL] [Abstract][Full Text] [Related]
4. Adaptive immunity: an emerging player in the progression of NAFLD.
Sutti S; Albano E
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):81-92. PubMed ID: 31605031
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease.
Byun JS; Yi HS
Biomed Res Int; 2017; 2017():6862439. PubMed ID: 28852648
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
Ceni E; Mello T; Galli A
World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
[TBL] [Abstract][Full Text] [Related]
7. OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis.
Sun G; Jin H; Zhang C; Meng H; Zhao X; Wei D; Ou X; Wang Q; Li S; Wang T; Sun X; Shi W; Tian D; Liu K; Xu H; Tian Y; Li X; Guo W; Jia J; Zhang Z; Zhang D
Cell Rep; 2018 Dec; 25(13):3786-3799.e4. PubMed ID: 30590049
[TBL] [Abstract][Full Text] [Related]
8. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.
Sutti S; Jindal A; Locatelli I; Vacchiano M; Gigliotti L; Bozzola C; Albano E
Hepatology; 2014 Mar; 59(3):886-97. PubMed ID: 24115128
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease.
Qiu LX; Chen T
World J Gastroenterol; 2015 Jan; 21(4):1099-107. PubMed ID: 25632182
[TBL] [Abstract][Full Text] [Related]
10. Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis.
Chen Y; Tian Z
Front Immunol; 2020; 11():1500. PubMed ID: 32765518
[TBL] [Abstract][Full Text] [Related]
11. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).
Nati M; Haddad D; Birkenfeld AL; Koch CA; Chavakis T; Chatzigeorgiou A
Rev Endocr Metab Disord; 2016 Mar; 17(1):29-39. PubMed ID: 26847547
[TBL] [Abstract][Full Text] [Related]
12. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
[TBL] [Abstract][Full Text] [Related]
13. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
[TBL] [Abstract][Full Text] [Related]
14. Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease.
Li S; Tan HY; Wang N; Feng Y; Wang X; Feng Y
Front Immunol; 2019; 10():1328. PubMed ID: 31244862
[TBL] [Abstract][Full Text] [Related]
15. Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling.
Barrow F; Khan S; Fredrickson G; Wang H; Dietsche K; Parthiban P; Robert S; Kaiser T; Winer S; Herman A; Adeyi O; Mouzaki M; Khoruts A; Hogquist KA; Staley C; Winer DA; Revelo XS
Hepatology; 2021 Aug; 74(2):704-722. PubMed ID: 33609303
[TBL] [Abstract][Full Text] [Related]
16. The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity.
Van Herck MA; Weyler J; Kwanten WJ; Dirinck EL; De Winter BY; Francque SM; Vonghia L
Front Immunol; 2019; 10():82. PubMed ID: 30787925
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
18. Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression.
Dallio M; Sangineto M; Romeo M; Villani R; Romano AD; Loguercio C; Serviddio G; Federico A
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406763
[TBL] [Abstract][Full Text] [Related]
19. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis?
Sundaram V; Morgan TR
Clin Liver Dis; 2019 Feb; 23(1):157-165. PubMed ID: 30454829
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol is a significant risk factor for non-alcoholic steatohepatitis.
Walenbergh SM; Shiri-Sverdlov R
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1343-6. PubMed ID: 26395315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
